{"id":4060,"date":"2010-06-16T04:00:23","date_gmt":"2010-06-16T08:00:23","guid":{"rendered":"https:\/\/smarttan.com\/blog\/index.php\/melanoma-being-over-diagnosed-study\/"},"modified":"2010-06-16T04:00:23","modified_gmt":"2010-06-16T08:00:23","slug":"melanoma-being-over-diagnosed-study","status":"publish","type":"post","link":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/","title":{"rendered":"Melanoma Being Over-diagnosed: Study"},"content":{"rendered":"<p><a rel=\"attachment wp-att-4061\" href=\"https:\/\/smarttan.com\/blog\/index.php\/melanoma-being-over-diagnosed-study\/2010-06-16-melanoma-diagnosis-copy\/\"><img decoding=\"async\" class=\"alignright size-full wp-image-4061\" style=\"margin: 5px 10px;\" title=\"2010-06-16 Melanoma diagnosis copy\" src=\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\" alt=\"2010-06-16 Melanoma diagnosis copy\" width=\"285\" height=\"150\" \/><\/a>Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn&#8217;t have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute.<\/p>\n<p>The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont.<\/p>\n<p>&#8220;For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),&#8221; the authors wrote. &#8220;Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.&#8221;<\/p>\n<p>The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis.<\/p>\n<p>&#8220;Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,&#8221; Welch and Black wrote.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn&#8217;t have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4060","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Melanoma Being Over-diagnosed: Study - Smart Tan News<\/title>\n<meta name=\"description\" content=\"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn&#039;t have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. &quot;For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),&quot; the authors wrote. &quot;Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.&quot; The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. &quot;Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,&quot; Welch and Black wrote.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanoma Being Over-diagnosed: Study - Smart Tan News\" \/>\n<meta property=\"og:description\" content=\"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn&#039;t have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. &quot;For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),&quot; the authors wrote. &quot;Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.&quot; The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. &quot;Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,&quot; Welch and Black wrote.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Smart Tan News\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SmartTan\" \/>\n<meta property=\"article:published_time\" content=\"2010-06-16T08:00:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\" \/>\n<meta name=\"author\" content=\"smarttan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SmartTan\" \/>\n<meta name=\"twitter:site\" content=\"@SmartTan\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"smarttan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\"},\"author\":{\"name\":\"smarttan\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b\"},\"headline\":\"Melanoma Being Over-diagnosed: Study\",\"datePublished\":\"2010-06-16T08:00:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\"},\"wordCount\":212,\"publisher\":{\"@id\":\"https:\/\/news.smarttan.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\",\"url\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\",\"name\":\"Melanoma Being Over-diagnosed: Study - Smart Tan News\",\"isPartOf\":{\"@id\":\"https:\/\/news.smarttan.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\",\"datePublished\":\"2010-06-16T08:00:23+00:00\",\"description\":\"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn't have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. \\\"For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),\\\" the authors wrote. \\\"Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.\\\" The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. \\\"Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,\\\" Welch and Black wrote.\",\"breadcrumb\":{\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage\",\"url\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\",\"contentUrl\":\"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/news.smarttan.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanoma Being Over-diagnosed: Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/news.smarttan.com\/#website\",\"url\":\"https:\/\/news.smarttan.com\/\",\"name\":\"Smart Tan News\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/news.smarttan.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/news.smarttan.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/news.smarttan.com\/#organization\",\"name\":\"Smart Tan\",\"url\":\"https:\/\/news.smarttan.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png\",\"contentUrl\":\"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png\",\"width\":500,\"height\":164,\"caption\":\"Smart Tan\"},\"image\":{\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SmartTan\",\"https:\/\/x.com\/SmartTan\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b\",\"name\":\"smarttan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g\",\"caption\":\"smarttan\"},\"url\":\"https:\/\/news.smarttan.com\/index.php\/author\/smarttan\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Melanoma Being Over-diagnosed: Study - Smart Tan News","description":"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn't have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. \"For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),\" the authors wrote. \"Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.\" The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. \"Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,\" Welch and Black wrote.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/","og_locale":"en_US","og_type":"article","og_title":"Melanoma Being Over-diagnosed: Study - Smart Tan News","og_description":"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn't have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. \"For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),\" the authors wrote. \"Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.\" The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. \"Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,\" Welch and Black wrote.","og_url":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/","og_site_name":"Smart Tan News","article_publisher":"https:\/\/www.facebook.com\/SmartTan","article_published_time":"2010-06-16T08:00:23+00:00","og_image":[{"url":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg","type":"","width":"","height":""}],"author":"smarttan","twitter_card":"summary_large_image","twitter_creator":"@SmartTan","twitter_site":"@SmartTan","twitter_misc":{"Written by":"smarttan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#article","isPartOf":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/"},"author":{"name":"smarttan","@id":"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b"},"headline":"Melanoma Being Over-diagnosed: Study","datePublished":"2010-06-16T08:00:23+00:00","mainEntityOfPage":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/"},"wordCount":212,"publisher":{"@id":"https:\/\/news.smarttan.com\/#organization"},"image":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage"},"thumbnailUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/","url":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/","name":"Melanoma Being Over-diagnosed: Study - Smart Tan News","isPartOf":{"@id":"https:\/\/news.smarttan.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage"},"image":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage"},"thumbnailUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg","datePublished":"2010-06-16T08:00:23+00:00","description":"Melanoma is among a group of cancers that are being over-diagnosed by a medical industry whose early detection and screening programs are finding smaller masses that wouldn't have been detected a generation ago and which most likely will not ever turn into cancers, according to a study published this week in the Journal of the National Cancer Institute. The paper was authored by Dr. H. Gilbert Welch and Dr. William C. Black of the Veterans Affairs Medical Center in Vermont. \"For melanoma, the rate of diagnosis has almost tripled (from 7.9 per 100,000 to 21.5 per 100,000), (but) the rate of death is generally stable (little change in the past 15 years),\" the authors wrote. \"Although there may be an element of a true increase in clinically significant melanoma, these data suggest that most of the increase in diagnosis reflects over-diagnosis.\" The paper comes on the heels of a paper from British dermatologists in 2009 showing the same thing \u2014 that there is not an actual increase in melanoma incidence, but rather an increase in diagnosis. \"Because almost all the new diagnoses are localized (or in situ) melanomas and because their appearance almost perfectly tracks the increase in population skin biopsy rates, over-diagnosis is likely the predominant explanation for the rise,\" Welch and Black wrote.","breadcrumb":{"@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#primaryimage","url":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg","contentUrl":"https:\/\/smarttan.com\/blog\/wp-content\/uploads\/2010\/06\/2010-06-16-Melanoma-diagnosis-copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/news.smarttan.com\/index.php\/melanoma-being-over-diagnosed-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/news.smarttan.com\/"},{"@type":"ListItem","position":2,"name":"Melanoma Being Over-diagnosed: Study"}]},{"@type":"WebSite","@id":"https:\/\/news.smarttan.com\/#website","url":"https:\/\/news.smarttan.com\/","name":"Smart Tan News","description":"","publisher":{"@id":"https:\/\/news.smarttan.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/news.smarttan.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/news.smarttan.com\/#organization","name":"Smart Tan","url":"https:\/\/news.smarttan.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/","url":"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png","contentUrl":"https:\/\/smarttan.com\/news\/wp-content\/uploads\/2022\/08\/Smart-Tan.png","width":500,"height":164,"caption":"Smart Tan"},"image":{"@id":"https:\/\/news.smarttan.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SmartTan","https:\/\/x.com\/SmartTan"]},{"@type":"Person","@id":"https:\/\/news.smarttan.com\/#\/schema\/person\/4191f4b1131c0a37b4fd39f876771e7b","name":"smarttan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/60bebff64d4c62315967b9126de927b81d5a9d9511fd52f9dbe9e8b344149182?s=96&d=mm&r=g","caption":"smarttan"},"url":"https:\/\/news.smarttan.com\/index.php\/author\/smarttan\/"}]}},"_links":{"self":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts\/4060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/comments?post=4060"}],"version-history":[{"count":1,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts\/4060\/revisions"}],"predecessor-version":[{"id":13715,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/posts\/4060\/revisions\/13715"}],"wp:attachment":[{"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/media?parent=4060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/categories?post=4060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.smarttan.com\/index.php\/wp-json\/wp\/v2\/tags?post=4060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}